These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 7932024)

  • 1. Recommended revisions to American Dental Association guidelines for acceptance of chemotherapeutic products for gingivitis control. Report of the Task Force on Design and Analysis in Dental and Oral Research to the Council on Therapeutics of the American Dental Association.
    Imrey PB; Chilton NW; Pihlstrom BL; Proskin HM; Kingman A; Listgarten MA; Zimmerman SO; Ciancio SG; Cohen ME; D'Agostino RB
    J Periodontal Res; 1994 Jul; 29(4):299-304. PubMed ID: 7932024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical studies for evaluation of chemotherapeutic agents for control of plaque and gingivitis.
    Khocht A
    J N J Dent Assoc; 1994; 65(2):15-8, 20-1. PubMed ID: 9520711
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical index systems used to assess the efficacy of mouthrinses on plaque and gingivitis.
    Fischman SL
    J Clin Periodontol; 1988 Sep; 15(8):506-10. PubMed ID: 3053792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological and measurement issues critical to design of gingivitis trials.
    Caton J
    J Periodontal Res; 1992 Jul; 27(4 Pt 2):364-8; discussion 373-4. PubMed ID: 1507025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposed guidelines for American Dental Association acceptance of products for professional, non-surgical treatment of adult periodontitis. Task Force on Design and Analysis in Dental and Oral Research.
    Imrey PB; Chilton NW; Pihlstrom BL; Proskin HM; Kingman A; Listgarten MA; Zimmerman SO; Ciancio SG; Cohen ME; D'Agostino RB
    J Periodontal Res; 1994 Sep; 29(5):348-60. PubMed ID: 7880252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for acceptance of chemotherapeutic products for the control of supragingival dental plaque and gingivitis. Council on Dental Therapeutics.
    J Am Dent Assoc; 1986 Apr; 112(4):529-32. PubMed ID: 3517110
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term effects of Listerine antiseptic on dental plaque and gingivitis.
    Ross NM; Charles CH; Dills SS
    J Clin Dent; 1989; 1(4):92-5. PubMed ID: 2700894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-gingivitis efficacy of a stabilized 0.454% stannous fluoride/sodium hexametaphosphate dentifrice.
    Mankodi S; Bartizek RD; Winston JL; Biesbrock AR; McClanahan SF; He T
    J Clin Periodontol; 2005 Jan; 32(1):75-80. PubMed ID: 15642062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical investigation of the efficacy of a commercial mouthrinse containing 0.05% cetylpyridinium chloride to control established dental plaque and gingivitis.
    Silva MF; dos Santos NB; Stewart B; DeVizio W; Proskin HM
    J Clin Dent; 2009; 20(2):55-61. PubMed ID: 19591338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of efficacy outcome variables for the evaluation of periodontal disease treatment.
    Page RC
    J Int Acad Periodontol; 2005 Oct; 7(4 Suppl):139-46. PubMed ID: 16248270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical research and the Council on Dental Therapeutics.
    Scholle RH
    Symp Pharmacol Ther Toxicol Group; 1975 Apr; ():38-44. PubMed ID: 775673
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of triclosan/copolymer dentifrice on dental plaque and gingivitis in a 3-month randomized controlled clinical trial: influence of baseline gingivitis on observed efficacy.
    McClanahan SF; Bartizek RD
    J Clin Dent; 2002; 13(4):167-78. PubMed ID: 12116727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled 6-month clinical trial to study the effects of a stannous fluoride dentifrice on gingivitis.
    Mallatt M; Mankodi S; Bauroth K; Bsoul SA; Bartizek RD; He T
    J Clin Periodontol; 2007 Sep; 34(9):762-7. PubMed ID: 17645550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific statistical considerations relevant to the design and analysis of gingivitis trials demonstrating product superiority or equivalence.
    Kingman A
    J Periodontal Res; 1992 Jul; 27(4 Pt 2):378-89; discussion 390-4. PubMed ID: 1507027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voluntary programs: ADA Seal program and international implications.
    Meyer DM
    Ann Periodontol; 1997 Mar; 2(1):31-41. PubMed ID: 9151541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of clinical trials of agents and procedures to prevent caries and periodontal disease: choosing products and recommending procedures.
    Addy M
    Int Dent J; 1995 Jun; 45(3):185-96. PubMed ID: 7558357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptance Program Guidelines. Chemotherapeutic agents to slow or arrest periodontitis. Council on Scientific Affairs. American Dental Association.
    J Periodontol; 1998 Sep; 69(9):1076-80. PubMed ID: 9776039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The how and why of the ADA's evaluation program for dental therapeutic products.
    Whall CW
    J Public Health Dent; 1992; 52(6):338-42. PubMed ID: 1432919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interim report of the ad hoc committee for the consideration of statistical concerns related to the use of intra-oral models in submissions for product claims approval to the American Dental Association.
    Proskin HM; Chilton NW; Kingman A
    J Dent Res; 1992 Apr; 71 Spec No():949-52. PubMed ID: 1592992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of mouthrinses for professional indications.
    Ciancio SG
    J Clin Periodontol; 1988 Sep; 15(8):520-3. PubMed ID: 3053795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.